List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 13 studies with search of: "4-Aminopyridine"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Study of Oral Fampridine-SR in Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Drug: Fampridine-SR (4-aminopyridine, 4-AP)
2 Completed Safety and Efficacy Study of Oral Fampridine-SR on Walking Ability in Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Drug: Fampridine-SR (4-aminopyridine, 4-AP)
3 Active, not recruiting Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR
Condition: Multiple Sclerosis
Intervention: Drug: Fampridine-SR
4 Active, not recruiting Study of Fampridine-SR Tablets in Multiple Sclerosis Patients Who Participated in the MS-F203 Trial
Condition: Multiple Sclerosis
Intervention: Drug: Fampridine-SR
5 Completed Assessment of Chronic Guillain-Barre Syndrome Improvement With Use of 4-Aminopyridine
Condition: Guillain-Barre Syndrome
Intervention: Drug: 4-aminopyridine (4-AP)
6 Active, not recruiting Open-Label Extension Study
Condition: Multiple Sclerosis
Intervention: Drug: Fampridine-SR
7 Completed Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
Condition: Multiple Sclerosis
Intervention: Drug: Fampridine-SR
8 Completed Safety and Efficacy of Oral Fampridine-SR for the Treatment of Spasticity Resulting From Spinal Cord Injury
Conditions: Spinal Cord Injury;   Muscle Spasticity
Intervention: Drug: Fampridine-SR
9 Completed Randomized Study of 3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome
Condition: Lambert-Eaton Myasthenic Syndrome
Intervention: Drug: 3,4-diaminopyridine
10 Recruiting Open Label Trial Of 3,4-Diaminopyridine In Lambert-Eaton Myasthenic Syndrome (LEMS)
Condition: Lambert-Eaton Myasthenic Syndrome
Intervention: Drug: 3,4-DIAMINOPYRIDINE
11 Recruiting Use of 3, 4-Diaminopyridine in Lambert Eaton Myasthenic Syndrome
Condition: Lambert Eaton Myasthenic Syndrome
Intervention: Drug: 3,4 Diaminopyridine
12 Recruiting Efficacy of 3,4-DAP in Fatigue Associated With Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Drug: 3,4-diaminopyridine
13 Completed Fatigue in Multiple Sclerosis: Evaluated With 3 MRI and Transcranial Magnetic Stimulation
Conditions: Multiple Sclerosis;   Fatigue
Interventions: Drug: 3,4-diaminopyridine;   Drug: Placebo

Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services